Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345(11):790–7.

CAS  PubMed  Google Scholar 

Bi Y, Wang T, Xu M, Xu Y, Li M, Lu J, et al. Advanced research on risk factors of type 2 diabetes. Diab Metabol Res Rev. 2012;28:32–9.

Google Scholar 

Chen L, Pei J-H, Kuang J, Chen H-M, Chen Z, Li Z-W, et al. Effect of lifestyle intervention in patients with type 2 diabetes: a meta-analysis. Metabolism. 2015;64(2):338–47.

CAS  PubMed  Google Scholar 

Ogurtsova K, da Rocha FJ, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diab Res Clin Pract. 2017;128:40–50.

CAS  Google Scholar 

Jafari-Adli S, Jouyandeh Z, Qorbani M, Soroush A, Larijani B, Hasani-Ranjbar S. Prevalence of obesity and overweight in adults and children in Iran; a systematic review. J Diab Metabol Dis. 2014;13(1):1–10.

Google Scholar 

Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med. 2008;14:741–51.

CAS  PubMed  PubMed Central  Google Scholar 

Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metabol. 2002;13(2):84–9.

CAS  Google Scholar 

Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85–97.

CAS  PubMed  PubMed Central  Google Scholar 

Gettins PG. Serpin structure, mechanism, and function. Chem Rev. 2002;102(12):4751–804.

CAS  PubMed  Google Scholar 

Law RH, Zhang Q, McGowan S, Buckle AM, Silverman GA, Wong W, et al. An overview of the serpin superfamily. Genome Biol. 2006;7:1–11.

Google Scholar 

Blüher M. Vaspin in obesity and diabetes: pathophysiological and clinical significance. Endocrine. 2012;41(2):176–82.

PubMed  Google Scholar 

Klöting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schön MR, et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun. 2006;339(1):430–6.

PubMed  Google Scholar 

Cash JL, Hart R, Russ A, Dixon JP, Colledge WH, Doran J, et al. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J Exp Med. 2008;205(4):767–75.

CAS  PubMed  PubMed Central  Google Scholar 

Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem. 2007;282(38):28175–88.

CAS  PubMed  Google Scholar 

Tan L, Lu X, Danser AJ, Verdonk K. The role of chemerin in metabolic and cardiovascular disease: a literature review of its physiology and pathology from a nutritional perspective. Nutrients. 2023;15(13):2878.

CAS  PubMed  PubMed Central  Google Scholar 

Najafi Z, Feizi MAH, Abbasaliizadeh S. Haplotype effect of two human leukocyte antigen-G polymorphisms of rs1736933 and rs2735022 on the recurrent pregnancy loss. J Inflamm Dis. 2021;24(5):398–409.

Google Scholar 

Hashemi M, Rezaei H, Eskandari-Nasab E, Zakeri Z, Taheri M. Association between chemerin rs17173608 and vaspin rs2236242 gene polymorphisms and the metabolic syndrome, a preliminary report. Gene. 2012;510(2):113–7.

CAS  PubMed  Google Scholar 

Mehanna ET, Mesbah NM, Ghattas MH, Saleh SM, Abo-Elmatty DM. Association of chemerin Rs17173608 and vaspin Rs2236242 gene polymorphisms with metabolic syndrome in Egyptian women. Endocr Res. 2016;41(1):43–8.

CAS  PubMed  Google Scholar 

Kwok S, Kellogg D, McKinney N, Spasic D, Goda L, Levenson C, et al. Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. Nucl Acids Res. 1990;18(4):999–1005.

CAS  PubMed  PubMed Central  Google Scholar 

Anscombe FJ. On estimating binomial response relations. Biometrika. 1956;43(3/4):461–4.

Google Scholar 

Haldane J. The mean and variance of| chi 2, when used as a test of homogeneity, when expectations are small. Biometrika. 1940;31(3/4):346–55.

Google Scholar 

Mambiya M, Shang M, Wang Y, Li Q, Liu S, Yang L, et al. The play of genes and non-genetic factors on type 2 diabetes. Front Public Health. 2019;7:349.

PubMed  PubMed Central  Google Scholar 

Wang CH, Wang CC, Huang HC, Wei YH. Mitochondrial dysfunction leads to impairment of insulin sensitivity and adiponectin secretion in adipocytes. FEBS J. 2013;280(4):1039–50.

CAS  PubMed  Google Scholar 

Abdelhamid AM, Zaafan MA. Association of chemerin rs17173608 and vaspin rs2236242 polymorphisms with type two diabetes mellitus and its impact on their corresponding serum levels in Egyptian population. 2019. ideas.

Rathwa N, Parmar N, Palit SP, Patel R, Ramachandran A, Begum R. Intron specific polymorphic site of vaspin gene along with vaspin circulatory levels can influence pathophysiology of type 2 diabetes. Life Sci. 2020;243: 117285.

CAS  PubMed  Google Scholar 

Hosseini M, Nezhadali M, Hedayati M. Association of vaspin rs2236242 gene polymorphism with serum vaspin level, insulin resistance and diabetes in an Iranian diabetic/pre-diabetic population. J Med Biochem. 2021;40(1):33.

CAS  PubMed  PubMed Central  Google Scholar 

Ghany SMA, Sayed AA, El-Deek SE, ElBadre HM, Dahpy MA, Saleh MA, et al. Obesity risk prediction among women of Upper Egypt: The impact of serum vaspin and vaspin rs2236242 gene polymorphism. Gene. 2017;626:140–8.

PubMed  Google Scholar 

Jian W, Peng W, Xiao S, Li H, Jin J, Qin L, et al. Role of serum vaspin in progression of type 2 diabetes: a 2-year cohort study. PLoS ONE. 2014;9(4): e94763.

PubMed  PubMed Central  Google Scholar 

Dai RongFeng DR, Dong ZhenHua DZ, Qian Yu QY, Han Yan HY. Obese type 2 diabetes mellitus patients have higher serum vaspin concentrations. 2016.

Yang W, Li Y, Tian T, Wang L. Serum vaspin concentration in elderly type 2 diabetes mellitus patients with differing body mass index: a cross-sectional study. BioMed Res Int. 2017;2017(1):4875026.

PubMed  PubMed Central  Google Scholar 

Breitfeld J, Wiele N, Gutsmann B, Stumvoll M, Blüher M, Scholz M, et al. Circulating adipokine VASPIN is associated with serum lipid profiles in humans. Lipids. 2019;54(4):203–10.

CAS  PubMed  Google Scholar 

Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology. 2007;148(10):4687–94.

CAS  PubMed  Google Scholar 

Yang M, Yang G, Dong J, Liu Y, Zong H, Liu H, et al. Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension. J Invest Med. 2010;58(7):883–6.

CAS  Google Scholar 

Sell H, Divoux A, Poitou C, Basdevant A, Bouillot J-L, Bedossa P, et al. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J Clin Endocrinol Metabol. 2010;95(6):2892–6.

CAS  Google Scholar 

Weigert J, Neumeier M, Wanninger J, Filarsky M, Bauer S, Wiest R, et al. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol. 2010;72(3):342–8.

CAS  Google Scholar 

Millar DS, Horan M, Chuzhanova NA, Cooper DN. Characterisation of a functional intronic polymorphism in the human growth hormone (GHI) gene. Human Genom. 2010;4:1–13.

Google Scholar 

Hasanvand Z, Sadeghi A, Rezvanfar MR, Goodarzi MT, Rahmannezhad G, Mashayekhi FJ. Association between chemerin rs17173608 and rs4721 gene polymorphisms and gestational diabetes mellitus in Iranian pregnant women. Gene. 2018;649:87–92.

CAS  PubMed  Google Scholar 

Becker M, Rabe K, Lebherz C, Zugwurst J, Göke B, Parhofer KG, et al. Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat diet. Diabetes. 2010;59(11):2898–903.

CAS  PubMed  PubMed Central  Google Scholar